- Home
- WNS vs HCM Comparison
WNS vs HCM Comparison
Compare WNS & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- HCM
- Stock Information
- Founded
- WNS 1996
- HCM 2000
- Country
- WNS India
- HCM Hong Kong
- Employees
- WNS N/A
- HCM N/A
- Industry
- WNS Business Services
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- WNS Consumer Discretionary
- HCM Health Care
- Exchange
- WNS Nasdaq
- HCM Nasdaq
- Market Cap
- WNS 2.5B
- HCM 2.5B
- IPO Year
- WNS N/A
- HCM N/A
- Fundamental
- Price
- WNS $55.22
- HCM $14.84
- Analyst Decision
- WNS Buy
- HCM Hold
- Analyst Count
- WNS 8
- HCM 1
- Target Price
- WNS $63.00
- HCM $19.00
- AVG Volume (30 Days)
- WNS 658.2K
- HCM 90.6K
- Earning Date
- WNS 07-17-2025
- HCM 07-30-2025
- Dividend Yield
- WNS N/A
- HCM N/A
- EPS Growth
- WNS 24.08
- HCM N/A
- EPS
- WNS 3.71
- HCM 0.04
- Revenue
- WNS $1,314,942,000.00
- HCM $630,201,000.00
- Revenue This Year
- WNS $5.56
- HCM $14.86
- Revenue Next Year
- WNS $9.37
- HCM $19.54
- P/E Ratio
- WNS $15.78
- HCM $66.84
- Revenue Growth
- WNS N/A
- HCM N/A
- 52 Week Low
- WNS $42.62
- HCM $11.51
- 52 Week High
- WNS $72.11
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- WNS 34.61
- HCM 46.89
- Support Level
- WNS $58.50
- HCM $15.02
- Resistance Level
- WNS $60.13
- HCM $18.00
- Average True Range (ATR)
- WNS 1.75
- HCM 0.42
- MACD
- WNS -0.13
- HCM -0.04
- Stochastic Oscillator
- WNS 10.25
- HCM 31.45
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.